[Optimization of cancer immunotherapy by controlling immune cell trafficking and biodistribution]

Naoki Okada1, Shinsaku Nakagawa

  • 1Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University, Yamadaoka, Suita City, Japan. okada@phs.osaka-u.ac.jp

Insights

Cancer immunotherapy faces challenges in achieving significant clinical responses. This study explores a novel cell delivery system using chemokine-chemokine receptor coupling to enhance immune cell trafficking for improved cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Context:

  • Tumor-associated antigens (TAAs) are crucial for cancer immunosurveillance.
  • Current cancer immunotherapies targeting TAAs show limited clinical efficacy.
  • Effective tumor regression and complete response remain elusive in clinical settings.

Purpose:

  • To introduce an innovative cell delivery system for cancer immunotherapy.
  • To enhance immune cell trafficking and biodistribution using chemokine-chemokine receptor coupling.
  • To improve the therapeutic effects of cancer immunotherapy.

Summary:

  • This review details approaches utilizing an Arg-Gly-Asp (RGD) fiber-mutant adenovirus vector.
  • The vector encodes chemokine or chemokine receptor genes to modulate immune cell migration.
  • This strategy aims to optimize leukocytic infiltration into tumor sites.

Impact:

  • Potential to overcome limitations of current cancer immunotherapy strategies.
  • Offers a novel method for controlling immune cell biodistribution in vivo.
  • May lead to improved therapeutic outcomes in cancer patients through enhanced immunosurveillance.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...